Thermo Fisher completes sale of microbiology business to Astorg for $1.08 billion
Reuters2026/08/12 12:03- Thermo Fisher completed the sale of its microbiology business to private equity firm Astorg for about $1.075 billion.
- Consideration comprised cash, backed by a $50 million seller note.
- The unit provides antimicrobial susceptibility testing, culture media for clinical, pharmaceutical, food safety testing.
- The business generated $645 million of revenue in 2025 within Thermo Fisher’s Specialty Diagnostics segment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Yelooo Integra Datanet corrects July securities holders registration report
Cakra Buana Resources Energi shareholder Republik Capital cuts stake to 9.3% from 11.3%
Preferred shares of South Korean companies are trading at a record 45% discount in ten years; Samsung's 110 trillion won buyback plan may help eliminate the "Korea discount"
Samsung Electronics' highly anticipated stock buyback plan is raising investor expectations that the South Korean giant will purchase non-voting preferred shares, narrowing their deep discount and setting a precedent for other companies.
Crypto prices
More
